|


Puerto Rico supports a large pharmaceutical
manufacturing infrastructure. With favorable tax incentives and
a sophisticated communications and transportation system, many
of the most prescribed medicines in the U.S. are manufactured in
Puerto Rico.
Like most islands with modern
infrastructure and manufacturing, Puerto Rico faces a finite
supply of resources – especially water. The pharmaceutical
giant, Pfizer has a leading manufacturing presence in Puerto
Rico, with five plants employing more than 5,500 people that
produce some of the company’s top selling medications including
Celebrex, Lipitor, Neurontin, Norvasc, Zoloft, and Zithromax. At
its facility in Fajardo, Puerto Rico, Pfizer initiated a water
conservation and waste minimization program with a goal of
reusing 100 percent of its wastewater.
In its drive towards making the plant a
zero discharge facility, Pfizer originally installed a reverse
osmosis (RO) to treat process water before returning it to
non-potable water uses. The RO system was installed to reduce
the volume of discharge water – 50,000 gallons per day - that
previously had to be loaded up in tankers around the clock and
trucked to a municipal waste treatment facility about two hours
away. The water supply to the Fajardo plant comes from surface
water originating from the nearby Yunque rain forest. Before
entering the plant, the water undergoes conventional treatment
from the municipality.
In
2002, Pfizer contacted ITT Industries’ Aquious unit to discuss
its wastewater treatment scheme. Pfizer was displeased with the
operation of its existing RO system. Installed without a
thorough engineering analysis, the RO system never operated
correctly from the start. According to Mainor Vega, products
manager for Latin America and the Caribbean with ITT Aquious’
Water Equipment Technologies unit, headquartered in Boynton
Beach, Fla, “When we visited the plant for the first time, they
had a waste bin filled with old membranes. The customer was
buying membranes on a monthly basis due to the inefficiency of
the existing RO system, which resulted in astronomical
operational costs.”
...Continued
in the pages of Twin Plant News, Subscribe Today! |